09 Jan What can digital health startups learn about commercialization from medtech and life science companies?
What can digital health startups learn about commercialization from medtech and life science companies?
‘As the healthcare industry shifts from a fee-for-service model in favor of value-based care, technology entrepreneurs see an opportunity for digital health tools to support this transformation. But the lengthy sales cycle for healthcare, the reality that the people/organizations footing the bill for this new technology are not necessarily the same groups who would be using it, coupled with the need for buy-in from clinicians and/or payers as well as investors, and one soon appreciates just how complex the path to commercialization can be.
This meaty topic of how digital health tech developers navigate this path is the subject of a panel discussion at the MedCity INVEST Twin Cities conference in Minneapolis October 11 and sponsored by Baker Tilly Virchow Krause, LLP. Panelists include: David Gregory, Principal, Healthcare consulting leader with Baker Tilly; John Brownlee, CEO of Vidscrip; and Anser Innovation CEO Lisa Lavin. Marcia Miller, Stone Arch president, will moderate.’
Read More: https://medcitynews.com/2018/10/digital-health-startups-and-commercialization/